Skip to main content

Takara Bio to Offer Pathogenica HAI Detection Kit in Japan

NEW YORK (GenomeWeb News) – Takara Bio said Monday that it has signed an agreement to offer Pathogenica's HAI BioDetection Kit in Japan as part of its sequencing services.

The sequencing-based kit enables identification of hospital acquired infections with a turnaround of less than 12 hours. According to Takara, the kit identifies what species are present in a sample and provides sequence data, including strain identity and resistance genes. Specifically, it can detect 12 bacteria commonly associated with HAIs and 15 resistance gene families in a single assay, and it can process 12 samples per sequencing run.

Shiga, Japan-based Takara Bio noted that the Pathogenica HAI BioDetection Kit is for research use only.

The firm also offers sequencing services through its Dragon Genomics Center.

Financial and other terms of the agreement were not disclosed.

Earlier this year Pathogenica signed an agreement with Life Technologies to distribute the test in Japan on the Ion Torrent platform.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.